Dolby Laboratories Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Dolby Laboratories stock.
View analyst ratings for Dolby Laboratories or view top-rated stocks.

Wall Street analysts have given Dolby Laboratories a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Dolby Laboratories wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Dolby Laboratories saw a decline in short interest in the month of August. As of August 13th, there was short interest totaling 508,500 shares, a decline of 13.7% from the July 29th total of 589,000 shares. Based on an average daily trading volume, of 340,200 shares, the days-to-cover ratio is currently 1.5 days. Approximately 0.8% of the shares of the stock are sold short.
View Dolby Laboratories' Short Interest.

Dolby Laboratories is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for Dolby Laboratories.

Dolby Laboratories, Inc. (NYSE:DLB) announced its quarterly earnings results on Thursday, July, 29th. The electronics maker reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.30 by $0.22. The electronics maker earned $286.80 million during the quarter, compared to analyst estimates of $276.06 million. Dolby Laboratories had a net margin of 23.11% and a trailing twelve-month return on equity of 11.41%.
View Dolby Laboratories' earnings history.

Dolby Laboratories' stock was trading at $60.23 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, DLB stock has increased by 59.3% and is now trading at $95.95.
View which stocks have been most impacted by COVID-19.

Dolby Laboratories announced a quarterly dividend on Friday, July 30th. Stockholders of record on Wednesday, August 11th will be given a dividend of $0.22 per share on Thursday, August 19th. This represents a $0.88 annualized dividend and a yield of 0.92%. The ex-dividend date of this dividend is Tuesday, August 10th.
View Dolby Laboratories' dividend history.

Dolby Laboratories pays an annual dividend of $0.88 per share and currently has a dividend yield of 0.92%. The dividend payout ratio of Dolby Laboratories is 38.26%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Dolby Laboratories will have a dividend payout ratio of 27.50% next year. This indicates that Dolby Laboratories will be able to sustain or increase its dividend.
View Dolby Laboratories' dividend history.

Dolby Laboratories updated its fourth quarter 2021 earnings guidance on Thursday, August, 5th. The company provided EPS guidance of $0.470-$0.620 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.660. The company issued revenue guidance of $280 million-$310 million, compared to the consensus revenue estimate of $304.83 million.

3 Wall Street analysts have issued twelve-month price targets for Dolby Laboratories' stock. Their forecasts range from $89.00 to $115.00. On average, they anticipate Dolby Laboratories' stock price to reach $102.00 in the next twelve months. This suggests a possible upside of 6.3% from the stock's current price.
View analysts' price targets for Dolby Laboratories or view top-rated stocks among Wall Street analysts.

253 employees have rated Dolby Laboratories CEO Kevin J. Yeaman on Glassdoor.com. Kevin J. Yeaman has an approval rating of 84% among Dolby Laboratories' employees.

Some companies that are related to Dolby Laboratories include Amphenol (APH), Corning (GLW), Littelfuse (LFUS), Rogers (ROG) and Vishay Intertechnology (VSH).
View all of DLB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include InterDigital (IDCC), Energy Transfer (ET), Advanced Micro Devices (AMD), AbbVie (ABBV), Abbott Laboratories (ABT), Bank of Hawaii (BOH), Mastercard (MA), STAG Industrial (STAG), Comcast (CMCSA) and NVIDIA (NVDA).

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.07%), BlackRock Inc. (3.76%), Clearbridge Investments LLC (3.43%), Atlanta Capital Management Co. L L C (3.23%), Jackson Square Partners LLC (2.73%) and Disciplined Growth Investors Inc. MN (1.48%). Company insiders that own Dolby Laboratories stock include Avadis Tevanian, Giles Baker, Kenneth D Knight, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay and Todd Pendleton.
View institutional ownership trends for Dolby Laboratories.

DLB stock was sold by a variety of institutional investors in the last quarter, including Ceredex Value Advisors LLC, Morgan Stanley, Morgan Stanley, Renaissance Technologies LLC, Mackenzie Financial Corp, Bank of Montreal Can, abrdn plc, and Wells Fargo & Company MN. Company insiders that have sold Dolby Laboratories company stock in the last year include Avadis Tevanian, Giles Baker, Kenneth D Knight, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay, and Todd Pendleton.
View insider buying and selling activity for Dolby Laboratories or view top insider-selling stocks.

DLB stock was purchased by a variety of institutional investors in the last quarter, including Atlanta Capital Management Co. L L C, Lazard Asset Management LLC, State Street Corp, Sunriver Management LLC, First Trust Advisors LP, Allianz Asset Management GmbH, Glenmede Trust Co. NA, and Man Group plc.
View insider buying and selling activity for Dolby Laboratories or or view top insider-buying stocks.

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DLB stock can currently be purchased for approximately $95.95.

Dolby Laboratories has a market capitalization of $9.73 billion and generates $1.16 billion in revenue each year. The electronics maker earns $231.36 million in net income (profit) each year or $2.30 on an earnings per share basis.

Dolby Laboratories employs 2,289 workers across the globe.

The following companies are subsidiares of Dolby Laboratories: Coding Technologies, Dolby International AB, Dolby Laboratories Licensing Corporation, Doremi Labs, Step Labs, and Voxeet.

Dolby Laboratories was founded in 1965.

The official website for Dolby Laboratories is www.dolby.com.

Dolby Laboratories is headquartered at 1275 MARKET STREET, SAN FRANCISCO CA, 94103.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at (415) 558-0200 or via email at [email protected]